XOMA Added to the Russell 2000® and Russell 3000® Indexes
EMERYVILLE, Calif., June 29, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) today announced the Company has been added to the Russell 2000® and Russell 3000® Indexes following the annual reconstitution, which took effect after more...
Pfenex Announces Positive European CHMP Opinion for PF708 (EU Brand Name: Livogiva(TM)) and New Partnership in Latin America, and Provides CRM197 Business Update
Pfenex Announces Positive European CHMP Opinion for PF708 (EU Brand Name: Livogiva(TM)) and New Partnership in Latin America, and Provides CRM197 Business Update (Sponsored)
Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for Livogiva marks important first step toward marketing authorization Pfenex’s commercial partner Adalvo entered into commercialization agreement in Latin America for PF708 with a more...
Alpine Begins Dosing in Phase I Study for Advanced Malignancies
Alpine Immune Sciences, Inc. ALPN announced that it has dosed the first patient in an early-stage study evaluating its cancer candidate, ALPN-202 for the treatment of patients with advanced malignancies. The phase I NEON-1 study more...